Splenic Non-Hodgkin Lymphoma — Trials

Splenic Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

166 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 35.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 51–100 of 166 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00089011	Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer	completed	Phase 2	150	Fred Hutchinson Cancer CenterOTHER	2	Jan 29, 2020	clinicaltrials
NCT00006251	Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer	completed	Phase 1 / Phase 2	21	Fred Hutchinson Cancer Center